The real-world safety of sacubitril / valsartan among older adults ( ≥75): A pharmacovigilance study from the FDA data

Heart failure is a major cause of morbidity and mortality among older adults. Sacubitril-Valsartan (Sac/Val) has been shown to improve patients' outcomes; however, its safety profile among older adults has not been adequately examined. We therefore aimed to examine its safety profile among this population.

Source: International Journal of Cardiology - November 27, 2023 Category: Cardiology Authors: Tsahi T. Lerman, Noam Greenberg, Boris Fishman, Adam Goldman, Yeela Talmor-Barkan, Bauer Menachem, Idan Goldberg, Elad Goldberg, Ran Kornowski, Ilan Krause, Amos Levi, Eytan Cohen Source Type: research